港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

抗疫概念

878.789

-11.619-1.30%

漲家數：3

跌家數：14

平家數：- -

市盈率：- -

高：889.460

開：889.460

低：870.070

收：890.408

成交量：3.01億

成交額：22.54億

市值：5,928.82億

流通市值：4,916.77億

資料載入中...

第4項！石藥EGFR ADC擬納入突破性療法

石藥集團(01093)：SYH2085片用於治療成人單純性流感的II期臨床試驗在中國正式啓動

中國生物製藥(01177.HK)：TQC3721吸入粉霧劑(PDE3/4抑制劑)於ERS 2026公布I期臨床研究數據

曾被估價1.54億元,如今2400萬元掛牌濟南平嘉大藥房60%股權再尋買家

復星醫藥(02196)9月7日斥資117.52萬港元回購7萬股

貝萊德在國藥控股的H股好倉比例下降0.15%至8.92%

南方财经网

破發股君實生物跌2.15% 2020年上市2募資共86億元

港股異動 | 比亞迪電子(00285.HK)升逾7% 主要客户旺季來臨疊加液冷產能逐步提升大摩看好後續業績改善

阿里健康(00241)出現大手買入130萬股，成交價$3.15，涉資409.5萬

阿斯达克财经

復星醫藥控股股東質押3.3億股還債累計質押比例超7成

教育部：把教師不必要的檢查、評比、填表真正減下來

港股異動 | 歌禮制藥-B(01672.HK)午後升逾6% 公司正式進入港股通名單 ASC30近期完成首例入組

同源康醫藥－Ｂ(02410)股價大幅下跌26.833%，現價港幣$4.54

阿斯达克财经

比亞迪電子(00285)出現大手賣出73萬股，成交價$25.66，涉資1.873千萬

阿斯达克财经

歌禮制藥納入港股通今日正式生效

歌禮制藥-B獲納入滬深港通下港股通名單

歌禮制藥-B(01672.HK)獲納入滬港通及深港通計劃項下的港股通名單

歌禮制藥－Ｂ(01672)股價下跌8.474%，現價港幣$9.235

阿斯达克财经

復星國際(00656.HK)：復星醫藥(02196.HK)減持印度注射劑藥品生產製造公司6%股權套現2.94億美元

阿斯达克财经

深交所：將歌禮制藥(01672)、曦智科技(01879)等調入深港通下的港股通標的

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BK1515/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":878.7892,"timestamp":1789114133774,"preClose":890.4082,"halted":0,"volume":300625831,"delay":0,"changeRate":-0.013049,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-11.619019,"latestTime":"09-11 16:00:00","open":889.45984,"high":889.45984,"low":870.06995,"amount":2253603899,"amplitude":0.021776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.318473,"peRate":17.086203,"turnoverRate":0.003644,"increases":3,"decrements":14,"flats":0,"marketCap":592881820352,"floatMarketCap":491676687872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":889.45984,"amplitude":0.021776,"preClose":890.4082,"low":870.06995,"pbRate":"1.318473","latestPrice":878.7892,"volume":300625831,"delay":0,"open":889.45984,"prevYearClose":1190.107,"prevWeekClose":936.431,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":936.431,"twentyDayClose":912.416,"sixtyDayClose":852.523,"secType":"PLATE","market":"HK","turnoverRate":0.003644,"peRate":17.086203,"marketCap":592881820352,"floatMarketCap":491676687872,"timestamp":1789114133774,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":3,"down":14,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665131464","title":"第4項！石藥EGFR ADC擬納入突破性療法","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131464","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131464?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:24","pubTimestamp":1788783840,"startTime":"0","endTime":"0","summary":"9月7日，CDE官网显示，石药集团的SYS6010拟纳入突破性疗法，用于免疫及含铂化疗治疗失败的复发或转移性驱动基因阴性非鳞非小细胞肺癌。SYS6010为石药创新制药旗下子公司巨石生物开发的一款EGFR ADC，由人源化抗EGFR单克隆抗体通过可裂解连接子与拓扑异构酶I抑制剂载荷偶联而成。2026年8月，SYS6010治疗EGFR-TKI治疗失败的EGFR突变型局部晚期或转移性NSCLC的III期研究达到主要终点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqzhfq9563252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0315179316.USD","LU1226287529.USD","LU0326950275.SGD","LU0501845795.SGD","IE0008368742.USD","LU0880133367.SGD","IE00B031HY20.USD","LU0314109678.HKD","LU1328277881.USD","LU1813983027.USD","LU0067412154.USD","IE00BZ08YS42.EUR","LU0072913022.USD","LU1226288253.USD","LU1008478684.HKD","LU1951186391.HKD","IE00B543WZ88.USD","HK0000165453.HKD","BK1515","LU1226287792.SGD","IE00BZ08YR35.GBP","LU0140636845.USD","LU2039709279.SGD","LU1226287875.USD","SG9999004220.SGD","IE0008369823.USD","01093","LU1226288170.HKD","LU1807302812.USD","LU1152091168.USD","LU1960683339.HKD","BK1191","LU1993786604.SGD","KURE","IE00BZ08YT58.USD","BK1521","LU1152091754.HKD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319978","title":"石藥集團(01093)：SYH2085片用於治療成人單純性流感的II期臨床試驗在中國正式啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319978","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319978?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:30","pubTimestamp":1788780616,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的SYH2085片用于治疗成人无并发症的单纯性流行性感冒的II期临床试验已于中国首家中心正式启动。此前，集团已于2025年12月获中国国家药品监督管理局就该产品签发的《药物临床试验批准通知书》。本次启动的该产品临床试验为多中心、随机、双盲、安慰剂对照的II期临床研究，旨在评价该产品治疗中国成人无并发症的单纯性流行性感冒参与者中的有效性及安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288170.HKD","IE0008368742.USD","LU1960683339.HKD","PSYK","LU1993786604.SGD","BK1521","LU1807302812.USD","MDTX","LU1226287529.USD","IE0008369823.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","HK0000165453.HKD","LU1008478684.HKD","BK1515","01093","IE00BZ08YR35.GBP","LU0315179316.USD","BMED","LU1328277881.USD","LU1152091754.HKD","LU0072913022.USD","LU0314109678.HKD","LU1226288253.USD","LU0067412154.USD","LU0326950275.SGD","LU1152091168.USD","LU1813983027.USD","KURE","LU1951186391.HKD","LU0501845795.SGD","LU1226287875.USD","BK1191","SG9999004220.SGD","LU2039709279.SGD","LU0880133367.SGD","IBBJ","LU0140636845.USD","IBBQ","IE00BZ08YS42.EUR","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131659","title":"中國生物製藥(01177.HK)：TQC3721吸入粉霧劑(PDE3/4抑制劑)於ERS 2026公布I期臨床研究數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131659","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131659?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:39","pubTimestamp":1788777571,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1521","BK1589","IE00BZ08YT58.USD","BK1515","HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319588","title":"曾被估價1.54億元,如今2400萬元掛牌 濟南平嘉大藥房60%股權再尋買家","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319588","media":"经济导报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319588?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:08","pubTimestamp":1788775680,"startTime":"0","endTime":"0","summary":"目前,济南平嘉股东分别为天士力医药和董红兵,持股比例分别为60%和40%。此次挂牌转让的,正是天士力医药所持有的60%股权。此次挂牌之所以引发关注,一个重要原因在于济南平嘉60%股权此前曾以较高价格进入市场视野。当时的评估结果显示,以2023年3月31日为评估基准日,济南平嘉100%股权评估值为26071.26万元,评估增值率达到1099.54%。如今,两年多时间过去,济南平嘉60%股权再次被摆上产权交易市场,挂牌底价已经变为2400万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqyzxs9592354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301017","BK1515","BK1574","BK0209","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315565","title":"復星醫藥(02196)9月7日斥資117.52萬港元回購7萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315565","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315565?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:00","pubTimestamp":1788775238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年9月7日，该公司斥资117.52万港元回购7万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492862.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","600196","BK1593","BK0012","BK0096","BK0188","BK0028","BK0187","BK0239","BK0175","02196","BK1191","BK1515","BK0183","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665313965","title":"貝萊德在國藥控股的H股好倉比例下降0.15%至8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665313965","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665313965?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 17:20","pubTimestamp":1788772800,"startTime":"0","endTime":"0","summary":"南财智讯9月7日电，香港交易所披露信息显示，BlackRock,Inc.（贝莱德）在国药控股的H股好仓（L）比例于9月2日从9.07%下降至8.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866754446.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866754446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","LU1115378108.SGD","LU0640798160.USD","BK1197","BK1515","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665188703","title":"破發股君實生物跌2.15% 2020年上市2募資共86億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665188703","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665188703?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:33","pubTimestamp":1788769993,"startTime":"0","endTime":"0","summary":"中国经济网北京9月7日讯 君实生物 今日收报32.77元，跌幅2.15%。该股目前处于破发状态。　　上市首日，君实生物股价最高报220.40元，为上市以来股价最高点。　　君实生物首次公开发行股票募集资金总额为48.36亿元，扣除发行费用后，募集资金净额为44.97亿元，较原计划多17.97亿元。　　君实生物首次公开发行股票发行费用为3.39亿元，其中，保荐及承销费用3.20亿元。　　经计算，君实生物两次募集资金合计86.12亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260907/32362114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","BK1583","BK1161","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665339795","title":"港股異動 | 比亞迪電子(00285.HK)升逾7% 主要客户旺季來臨疊加液冷產能逐步提升 大摩看好後續業績改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2665339795","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665339795?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:32","pubTimestamp":1788766347,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0274383008.USD","LU0348766576.USD","BK1589","BK1149","BK1515","00285","BK1504","BK1167","BK1582","BK1607","BK1580","LU0348767384.USD","BK1540"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392139","title":"阿里健康(00241)出現大手買入130萬股，成交價$3.15，涉資409.5萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392139","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392139?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:54","pubTimestamp":1788764040,"startTime":"0","endTime":"0","summary":"[大手成交]阿里健康(00241)在下午02:54出现大手买入，成交量为130万，成交价为港币$3.15，涉资409.5万。至目前为止，股价升0.159%，今日最高价为$3.16，而最低价为$3.115，总成交量为1.884千万股，总成交金额港币$5.909千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609076083/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609076083/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1501","BK1617","BK1610","BK1502","BK1515","00241","BK1247","BK1571","BK1189","BK1591","HK0000165453.HKD","BK1615","BK1142","BK1584","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392895","title":"復星醫藥控股股東質押3.3億股還債 累計質押比例超7成","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392895","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392895?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:37","pubTimestamp":1788763023,"startTime":"0","endTime":"0","summary":"中国经济网北京9月7日讯 复星医药 9月5日披露的关于股东部分股份质押的公告显示，公司于2026年9月4日接到控股股东上海复星高科技(集团)有限公司的通知，其已将所持有的公司部分A股股份办理质押手续。　　复星高科技本次质押股份数量为3.3亿股，占其所持股份数比例的34.32%，占公司股份总数比例为12.36%。质押起始日为2026年9月3日，质押到期日为2028年9月8日。　　控股股东复星高科技质押公司股份均系用于融资。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/07/20260907896860.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/07/20260907896860.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260907/32361887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["600196","BK0060","BK0188","BK0187","BK0196","BK0028","BK0239","BK1593","BK0175","BK1191","BK0183","BK0012","BK1515","BK0096","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665539490","title":"教育部：把教師不必要的檢查、評比、填表真正減下來","url":"https://stock-news.laohu8.com/highlight/detail?id=2665539490","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665539490?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:27","pubTimestamp":1788762449,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1501","BK1617","BK1610","BK1502","BK1515","00241","BK1247","BK1571","BK1189","BK1591","HK0000165453.HKD","BK1615","BK1142","BK1584","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394527","title":"港股異動 | 歌禮制藥-B(01672.HK)午後升逾6% 公司正式進入港股通名單  ASC30近期完成首例入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394527?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:15","pubTimestamp":1788761745,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1515","BK1191","BK1574","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394677","title":"同源康醫藥－Ｂ(02410)股價大幅下跌26.833%，現價港幣$4.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394677","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394677?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:04","pubTimestamp":1788761040,"startTime":"0","endTime":"0","summary":"[下跌股]同源康医药－Ｂ(02410) 股价在下午02:04比前收市价大幅下跌26.833%，现股价为港币$4.54。至目前为止，今日最高价为$5.905，而最低价为$4.54。总成交量为538.3万股，总成交金额为港币$2.673千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609072429/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609072429/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1161","BK1574","02410","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665697391","title":"比亞迪電子(00285)出現大手賣出73萬股，成交價$25.66，涉資1.873千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2665697391","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665697391?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 13:25","pubTimestamp":1788758700,"startTime":"0","endTime":"0","summary":"[大手成交]比亚迪电子(00285)在下午01:25出现大手卖出，成交量为73万，成交价为港币$25.66，涉资1.873千万。至目前为止，股价升2.385%，今日最高价为$25.92，而最低价为$25.06，总成交量为659.13万股，总成交金额港币$1.687亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609074959/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609074959/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1580","00285","LU0348767384.USD","LU0348766576.USD","BK1540","BK1589","BK1607","BK1504","BK1167","BK1582","LU0274383008.USD","BK1515","BK1149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399941","title":"歌禮制藥納入港股通 今日正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399941","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399941?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:25","pubTimestamp":1788755100,"startTime":"0","endTime":"0","summary":"歌礼制药（01672）发布公告，公司于2026年9月7日起，获纳入沪港通及深港通计划下的港股通名单。此次纳入将使符合相关资格的国内投资者能够通过港股通渠道交易公司股票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866532228.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866532228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","BK1515","01477","01672","FLHK","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164090375","title":"歌禮制藥-B獲納入滬深港通下港股通名單","url":"https://stock-news.laohu8.com/highlight/detail?id=1164090375","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164090375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:18","pubTimestamp":1788754680,"startTime":"0","endTime":"0","summary":"歌礼制药-B（Ascletis-B）宣布，公司已成功入选港股通名单，该名单适用于上海-香港股票市场交易互联互通机制以及深圳-香港股票市场交易互联互通机制。这一里程碑式的进展，标志着公司股票正式进入沪深港通体系，为两地投资者提供了更为便捷的投资通道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352399","title":"歌禮制藥-B(01672.HK)獲納入滬港通及深港通計劃項下的港股通名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352399?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:16","pubTimestamp":1788754601,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1161","01672","BK1515","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665954633","title":"歌禮制藥－Ｂ(01672)股價下跌8.474%，現價港幣$9.235","url":"https://stock-news.laohu8.com/highlight/detail?id=2665954633","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665954633?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:35","pubTimestamp":1788748500,"startTime":"0","endTime":"0","summary":"[下跌股]歌礼制药－Ｂ(01672) 股价在上午10:35比前收市价下跌8.474%，现股价为港币$9.235。至目前为止，今日最高价为$10.57，而最低价为$9.235。总成交量为287.599万股，总成交金额为港币$2.858千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609071531/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609071531/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1574","BK1515","BK1161","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665839583","title":"復星國際(00656.HK)：復星醫藥(02196.HK)減持印度注射劑藥品生產製造公司6%股權  套現2.94億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665839583","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665839583?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:03","pubTimestamp":1788746580,"startTime":"0","endTime":"0","summary":"复星国际公布，附属复星医药全资附属复星医药新加坡公司，通过大宗交易及集中竞价方式出售共计989.7万股Gland Pharma Limited股份，约占该公司股份总数的6%，出售事项的总代价约为279.96亿卢比。Gland Pharma Limited是一间根据印度法律成立的公司，其主要从事注射剂药品的生产制造业务，其股份于孟买证券交易所及印度国家证券交易所上市，股份代号：GLAND。于出售事项前及完成后，复星国际分别持有Gland Pharma约51.76%及45.76%的股权，该公司仍为复星医药及复星国际的附属。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220902164047308_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220902164047308_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543112/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543112/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["600196","BK0096","BK0175","BK0187","BK0239","BK1515","BK0196","BK0183","BK0188","BK0028","BK0060","BK1593","02196","BK0012","BK1230","MNDmain","BK1191","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665930583","title":"深交所：將歌禮制藥(01672)、曦智科技(01879)等調入深港通下的港股通標的","url":"https://stock-news.laohu8.com/highlight/detail?id=2665930583","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665930583?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:57","pubTimestamp":1788746223,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月7日，深交所公告，根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自2026年09月07日起生效。调入歌礼制药(01672)、曦智科技(01879)、百度集团(09888)等，调出日清食品(01475)、海昌海洋公园(02255)、狮腾控股(02562)等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260907/32361455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["FLHK","BK1515","01879","01477","BK1191","BK1163","BK1161","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":5,"totalSize":219,"code":"91000000","status":"200"}]}}